Edgewell Personal Care's analyst price target remains unchanged at $23.86. Analysts highlight only minor adjustments in underlying discount rates and profit margin projections, with no significant new research influencing the valuation.
What's in the News
- Edgewell Personal Care Company provided earnings guidance for fiscal year 2026, projecting net sales growth between 0.5% and 3.5%, organic net sales ranging from a 1% decrease to a 2% increase, and GAAP EPS between $1.10 and $1.50 (Key Developments).
- The company announced a share repurchase program, authorizing up to $100 million in buybacks (Key Developments).
- The Board of Directors approved a new buyback plan on November 13, 2025 (Key Developments).
- Regarding the repurchase program, as of September 30, 2025, the company has completed the buyback of 9,773,306 shares, amounting to 19.2% of shares for $356.96 million since the 2018 authorization (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at $23.86.
- Discount Rate has risen slightly from 10.93% to 11.35%.
- Revenue Growth projection is stable at approximately 1.32%.
- Net Profit Margin has fallen slightly from 8.41% to 8.16%.
- Future P/E ratio has increased modestly from 6.87x to 7.16x.
Have other thoughts on Edgewell Personal Care?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.